Global Livestock Animal Vaccines Sales Market by Type (Live Attenuated Vaccine, Inactivated Vaccine, Other Vaccines), By Application (Pig, Cattle, Poultry, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
The Global Livestock Animal Vaccines Market Size is expected to grow at a CAGR of 5.6% during the forecast period and the market is expected to reach USD 7.6 billion by 2028. The growth of this market can be attributed to the increase in demand for poultry and swine vaccines due to the presence of various zoonotic diseases including influenza virus, Newcastle disease, avian flu, etc.
Livestock animal vaccines are used to prevent various diseases in animals, for example, pigs. The vaccine is composed of a virus that has been weakened or killed so it does not cause illness but can still make the body produce antibodies against the disease-causing agent. These agents provide immunity from the infection and some also contain adjuvants which enhance the immune response by increasing inflammation at injection sites and improve the efficacy of vaccines.
On the basis of Types, the market is segmented into Live Attenuated Vaccine, Inactivated Vaccine, and Other Vaccines. Live attenuated vaccine is the most commonly used type of livestock animal vaccine as it has a better effect on animals and causes fewer complications in humans.
Live Attenuated Vaccine:
Live attenuated vaccines are used to treat illnesses, such as rabies. Live Attenuated Vaccines can either be modified live or killed virus. One of the major factors in determining a vaccine's efficacy is its ability to replicate and establish immunity without causing illness. Live attenuated vaccine is the most commonly used type of livestock animal vaccine as it has a better effect on animals and causes fewer complications in humans.
Inactivated Vaccine:
Inactivated vaccines are used to prevent and control diseases by using inactivating or killing the organisms responsible for them. They can also be called killed, toxoid vaccines, procaine hydrochloride-injectable vaccine (PHT), formaldehyde-killed vaccine, or formalin-vaccine. An example of an inactivated vaccination is rabies; an organism that lives in animal bites will infect humans if they do not receive a shot soon after contact with it. Rabies causes brain infections leading to death without treatment so getting vaccinated shortly after being bitten is critical before symptoms start showing up.
On the basis of Application, the market is segmented into Pig, Cattle, Poultry, and Others.
Pig:
The use of Livestock Animal Vaccines in Pig is to prevent diseases. The vaccine can be used for protection, control, and eradication purposes depending on the disease. Diseases such as 'swine fever', paratyphoid, erysipelas (a bacterial infection) are prevented with livestock animal vaccines.
Cattle:
Livestock animal vaccines are utilized for the prevention of diseases like Foot and Mouth Disease (FMD), Hanta Virus, Bluetongue, Bovine Viral Diarrhea Virus, Avian Influenza. These vaccines are used to prevent disease outbreaks in cattle through immunization against infectious pathogens that cause these conditions. Global demand for Livestock Animal Vaccines is driven by the rising adoption of livestock animals as part of a sustainable food production system due to the rise in population growth rates globally.
Poultry:
The use of livestock animal vaccines in the poultry sector has a lot to do with the control and prevention of diseases prevalent in this industry. A vaccine is an attenuated form of a pathogen that causes it not to produce any harmful effects on its host, but still offers immunity against future exposure. When used properly, these products can offer protection from various pathogens such as Newcastle disease virus (NDV), avian influenza virus (AI), fowl poxvirus (FPX), etc., which are transmitted through airborne or direct contact between animals and humans. A reduction in vaccination coverage could lead to outbreaks among poultry due to the lack of herd immunity offered by vaccinations over time. Hence they need adequate doses for an effective immunization success rate to be achieved.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Among these regions, North America is expected to lead in terms of revenue generation for all vaccine types during the forecast period (2021-2028) on account of its larger livestock population and export rates.
Growth Factors For The Global Livestock Animal Vaccines Market:
- The growth can be attributed to increasing awareness about livestock animal diseases which will drive demand for vaccines as well as the continuous development of new livestock animal vaccine products.
- Growing Livestock Population and Rising Demand for Animal Products To Drive The Market Growth
- Increasing Import of Animals to Developing Countries is Driving the Expansion.
- Increase in Domestic Production of Animal Protein and Rising Demand for Livestock Animals
- Growth In The Poultry Industry to Boost the Market Demand.
Up Market Research published a new report titled “Livestock Animal Vaccines Sales Market research report which is segmented by Types (Live Attenuated Vaccine, Inactivated Vaccine, Other Vaccines), By Applications (Pig, Cattle, Poultry, Others), By Players/Companies Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Yebio, DHN, Kyoto Biken Laboratories, WINSUN, FATRO, CAVAC, MEVAC, Biovac, ChengDu Tecbond, Vaksindo, Bio-Labs”.
Report Scope
| Report Attributes | Report Details |
| Report Title | Livestock Animal Vaccines Sales Market Research Report |
| By Type | Live Attenuated Vaccine, Inactivated Vaccine, Other Vaccines |
| By Application | Pig, Cattle, Poultry, Others |
| By Companies | Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Yebio, DHN, Kyoto Biken Laboratories, WINSUN, FATRO, CAVAC, MEVAC, Biovac, ChengDu Tecbond, Vaksindo, Bio-Labs |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 214 |
| Number of Tables & Figures | 150 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Livestock Animal Vaccines Sales Market Report Segments:
The market is segmented by Type Live Attenuated Vaccine, Inactivated Vaccine, Other Vaccines and By Application Pig, Cattle, Poultry, Others.
Some of the companies that are profiled in this report are:
- Merck
- Boehringer Ingelheim
- Zoetis
- Ceva
- Elanco
- CAHIC
- Jinyu Bio-Technology
- HVRI
- Ringpu Biology
- Yebio
- DHN
- Kyoto Biken Laboratories
- WINSUN
- FATRO
- CAVAC
- MEVAC
- Biovac
- ChengDu Tecbond
- Vaksindo
- Bio-Labs
Livestock Animal Vaccines Sales Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Livestock Animal Vaccines Sales Market
Overview of the regional outlook of the Livestock Animal Vaccines Sales Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Livestock Animal Vaccines Sales Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Livestock Animal Vaccines Sales Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. Live Attenuated Vaccine
2. Inactivated Vaccine
3. Other Vaccines
7. By Application:1. Pig
2. Cattle
3. Poultry
4. Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Livestock Animal Vaccines Sales Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Livestock Animal Vaccines Sales Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Livestock Animal Vaccines Sales Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Livestock Animal Vaccines Sales Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Livestock Animal Vaccines Sales Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Livestock Animal Vaccines Sales Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Livestock Animal Vaccines Sales Market Size & Forecast, 2018-2028
4.5.1 Livestock Animal Vaccines Sales Market Size and Y-o-Y Growth
4.5.2 Livestock Animal Vaccines Sales Market Absolute $ Opportunity
Chapter 5 Global Livestock Animal Vaccines Sales Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Livestock Animal Vaccines Sales Market Size Forecast by Type
5.2.1 Live Attenuated Vaccine
5.2.2 Inactivated Vaccine
5.2.3 Other Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Livestock Animal Vaccines Sales Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Livestock Animal Vaccines Sales Market Size Forecast by Applications
6.2.1 Pig
6.2.2 Cattle
6.2.3 Poultry
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Livestock Animal Vaccines Sales Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Livestock Animal Vaccines Sales Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Livestock Animal Vaccines Sales Analysis and Forecast
9.1 Introduction
9.2 North America Livestock Animal Vaccines Sales Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Livestock Animal Vaccines Sales Market Size Forecast by Type
9.6.1 Live Attenuated Vaccine
9.6.2 Inactivated Vaccine
9.6.3 Other Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Livestock Animal Vaccines Sales Market Size Forecast by Applications
9.10.1 Pig
9.10.2 Cattle
9.10.3 Poultry
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Livestock Animal Vaccines Sales Analysis and Forecast
10.1 Introduction
10.2 Europe Livestock Animal Vaccines Sales Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Livestock Animal Vaccines Sales Market Size Forecast by Type
10.6.1 Live Attenuated Vaccine
10.6.2 Inactivated Vaccine
10.6.3 Other Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Livestock Animal Vaccines Sales Market Size Forecast by Applications
10.10.1 Pig
10.10.2 Cattle
10.10.3 Poultry
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Livestock Animal Vaccines Sales Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Livestock Animal Vaccines Sales Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Livestock Animal Vaccines Sales Market Size Forecast by Type
11.6.1 Live Attenuated Vaccine
11.6.2 Inactivated Vaccine
11.6.3 Other Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Livestock Animal Vaccines Sales Market Size Forecast by Applications
11.10.1 Pig
11.10.2 Cattle
11.10.3 Poultry
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Livestock Animal Vaccines Sales Analysis and Forecast
12.1 Introduction
12.2 Latin America Livestock Animal Vaccines Sales Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Livestock Animal Vaccines Sales Market Size Forecast by Type
12.6.1 Live Attenuated Vaccine
12.6.2 Inactivated Vaccine
12.6.3 Other Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Livestock Animal Vaccines Sales Market Size Forecast by Applications
12.10.1 Pig
12.10.2 Cattle
12.10.3 Poultry
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Livestock Animal Vaccines Sales Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Livestock Animal Vaccines Sales Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Livestock Animal Vaccines Sales Market Size Forecast by Type
13.6.1 Live Attenuated Vaccine
13.6.2 Inactivated Vaccine
13.6.3 Other Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Livestock Animal Vaccines Sales Market Size Forecast by Applications
13.10.1 Pig
13.10.2 Cattle
13.10.3 Poultry
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Livestock Animal Vaccines Sales Market: Competitive Dashboard
14.2 Global Livestock Animal Vaccines Sales Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Boehringer Ingelheim
14.3.3 Zoetis
14.3.4 Ceva
14.3.5 Elanco
14.3.6 CAHIC
14.3.7 Jinyu Bio-Technology
14.3.8 HVRI
14.3.9 Ringpu Biology
14.3.10 Yebio
14.3.11 DHN
14.3.12 Kyoto Biken Laboratories
14.3.13 WINSUN
14.3.14 FATRO
14.3.15 CAVAC
14.3.16 MEVAC
14.3.17 Biovac
14.3.18 ChengDu Tecbond
14.3.19 Vaksindo
14.3.20 Bio-Labs
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Livestock Animal Vaccines Sales Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Livestock Animal Vaccines Sales Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Livestock Animal Vaccines Sales Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Livestock Animal Vaccines Sales Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Livestock Animal Vaccines Sales Market Size & Forecast, 2018-2028
4.5.1 Livestock Animal Vaccines Sales Market Size and Y-o-Y Growth
4.5.2 Livestock Animal Vaccines Sales Market Absolute $ Opportunity
Chapter 5 Global Livestock Animal Vaccines Sales Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Livestock Animal Vaccines Sales Market Size Forecast by Type
5.2.1 Live Attenuated Vaccine
5.2.2 Inactivated Vaccine
5.2.3 Other Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Livestock Animal Vaccines Sales Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Livestock Animal Vaccines Sales Market Size Forecast by Applications
6.2.1 Pig
6.2.2 Cattle
6.2.3 Poultry
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Livestock Animal Vaccines Sales Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Livestock Animal Vaccines Sales Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Livestock Animal Vaccines Sales Analysis and Forecast
9.1 Introduction
9.2 North America Livestock Animal Vaccines Sales Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Livestock Animal Vaccines Sales Market Size Forecast by Type
9.6.1 Live Attenuated Vaccine
9.6.2 Inactivated Vaccine
9.6.3 Other Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Livestock Animal Vaccines Sales Market Size Forecast by Applications
9.10.1 Pig
9.10.2 Cattle
9.10.3 Poultry
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Livestock Animal Vaccines Sales Analysis and Forecast
10.1 Introduction
10.2 Europe Livestock Animal Vaccines Sales Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Livestock Animal Vaccines Sales Market Size Forecast by Type
10.6.1 Live Attenuated Vaccine
10.6.2 Inactivated Vaccine
10.6.3 Other Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Livestock Animal Vaccines Sales Market Size Forecast by Applications
10.10.1 Pig
10.10.2 Cattle
10.10.3 Poultry
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Livestock Animal Vaccines Sales Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Livestock Animal Vaccines Sales Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Livestock Animal Vaccines Sales Market Size Forecast by Type
11.6.1 Live Attenuated Vaccine
11.6.2 Inactivated Vaccine
11.6.3 Other Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Livestock Animal Vaccines Sales Market Size Forecast by Applications
11.10.1 Pig
11.10.2 Cattle
11.10.3 Poultry
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Livestock Animal Vaccines Sales Analysis and Forecast
12.1 Introduction
12.2 Latin America Livestock Animal Vaccines Sales Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Livestock Animal Vaccines Sales Market Size Forecast by Type
12.6.1 Live Attenuated Vaccine
12.6.2 Inactivated Vaccine
12.6.3 Other Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Livestock Animal Vaccines Sales Market Size Forecast by Applications
12.10.1 Pig
12.10.2 Cattle
12.10.3 Poultry
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Livestock Animal Vaccines Sales Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Livestock Animal Vaccines Sales Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Livestock Animal Vaccines Sales Market Size Forecast by Type
13.6.1 Live Attenuated Vaccine
13.6.2 Inactivated Vaccine
13.6.3 Other Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Livestock Animal Vaccines Sales Market Size Forecast by Applications
13.10.1 Pig
13.10.2 Cattle
13.10.3 Poultry
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Livestock Animal Vaccines Sales Market: Competitive Dashboard
14.2 Global Livestock Animal Vaccines Sales Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Boehringer Ingelheim
14.3.3 Zoetis
14.3.4 Ceva
14.3.5 Elanco
14.3.6 CAHIC
14.3.7 Jinyu Bio-Technology
14.3.8 HVRI
14.3.9 Ringpu Biology
14.3.10 Yebio
14.3.11 DHN
14.3.12 Kyoto Biken Laboratories
14.3.13 WINSUN
14.3.14 FATRO
14.3.15 CAVAC
14.3.16 MEVAC
14.3.17 Biovac
14.3.18 ChengDu Tecbond
14.3.19 Vaksindo
14.3.20 Bio-Labs
Segments Covered in the Report
The global Livestock Animal Vaccines Sales market has been segmented based on
By Types
The global Livestock Animal Vaccines Sales market has been segmented based on
By Types
- Live Attenuated Vaccine
- Inactivated Vaccine
- Other Vaccines
- Pig
- Cattle
- Poultry
- Others
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Merck
- Boehringer Ingelheim
- Zoetis
- Ceva
- Elanco
- CAHIC
- Jinyu Bio-Technology
- HVRI
- Ringpu Biology
- Yebio
- DHN
- Kyoto Biken Laboratories
- WINSUN
- FATRO
- CAVAC
- MEVAC
- Biovac
- ChengDu Tecbond
- Vaksindo
- Bio-Labs
Our Clients
Related Reports
Some other reports from this category!
